Ticker Symbol: ADYX
Adynxx Inc
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001054274
Company Profile
alliqua biomedical, inc. (nasdaq:alqa) ("alliqua") is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion gmbh & co. kg and celgene cellular therapeutics, a subsidiary of celgene corporation. alliqua's contract manufacturing business unit provides custom hydrogels to the oem market. the company is headquartered in langhorne, pa.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 2150 Cabot Blvd West
Website: http://alliqua.com/
CEO: David Johnson
Tags:
- Pharmaceuticals: Major
- Health Technology
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.00 - $0.00
Beta: -
52wk. High: $0.00
52wk. Low: $0.00
Ytd. Change 0.00%
50 Day Moving Average: $0.00
200 Day Moving Average: $0.00
Shares Outstanding: 5807877
Valuation
Market Cap: $581.00
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A